Merck And Vericel Incorporate Insights on How Receptive the Industry Is for Advancing Rapid Diagnostic Technologies

Monday, May 22, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, May 22, 2017 /PRNewswire/ -- Returning with the 7th in its series, Pharmaceutical Microbiology West Coast

continues the trend of uniting international microbiology leaders in advancing microbial sciences across the globe.

This conference will bring together microbiologists, to provide attendees with new findings within the microbiology field as well

as the opportunity to network, learn and develop professionally over the course of two days.

SMi's Microbiology West Coast 2017 event has been produced to enable the exploration of science through one of five specialized sessions, representing unique areas of inquiry and specific disciplines.

With the impending changes to annexe 1, rapid microbiological testing is gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical application as well as in other industrial settings. Additionally, rapid microbiology tests offer faster and more accurate methods to assist in the rapid detection of microbes and early diagnosis, therefore saving cost and inventory.

Merck and Vericel will be incorporating their insights on the market and how receptive the industry is for advancing rapid diagnostic technologies to improve the turnaround time of tests as compared to the conventional microbiology testing methods, whilst maintaining data integrity and compliance.

There are several highlights that this year's attendees will benefit from, including:

- Inspiring keynote presentations from the brightest minds in microbiology

- Multidisciplinary plenary sessions combining clinical and basic science

- In-depth data integrity and compliance presentations

- Direct regulatory feedback

- Interdisciplinary sessions highlighting the latest research of environmental modelling

- Interactive training session of the effects of cleanrooms and barriers systems on environmental monitoring data

SMi's objective for this year's conference is to promote and advance the microbial sciences. To successfully achieve that, the agenda has been constructed to nurture and promote the innovation and hard work of scientists, clinicians and educators.

There is currently a limited special rate for all pharma companies, for further information please contact Fateja Begum at [email protected] or call +44 (0) 20 7827 6184

Registration for this event is closing soon. If you'd like to join your colleagues for keynote presentations and interdisciplinary plenary sessions that spotlight transcendent science, visit www.pharma-microbiology-usa.com to register.

Pharmaceutical Microbiology West Coast

8 - 9 June 2017

San Diego, California, USA

www.pharma-microbiology-usa.com

#smimicrobiology

For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail [email protected].

For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email

[email protected]

Photo(s): https://www.prlog.org/12641059

Press release distributed by PRLog

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/merck-and-vericel-incorporate-insights-on-how-receptive-the-industry-is-for-advancing-rapid-diagnostic-technologies-300461234.html

SOURCE SMi Group



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store